BrightAccountsProduction v1.0.0 v1.0.0 2025-02-01 The company was not dormant during the period The company was trading for the entire period Unaudited Accounts The principal activity of the company was that of a pharmacy. 29 April 2026 58 50 NI635541 2026-01-31 NI635541 2025-01-31 NI635541 2024-01-31 NI635541 2025-02-01 2026-01-31 NI635541 2024-02-01 2025-01-31 NI635541 uk-bus:PrivateLimitedCompanyLtd 2025-02-01 2026-01-31 NI635541 uk-curr:PoundSterling 2025-02-01 2026-01-31 NI635541 uk-bus:SmallCompaniesRegimeForAccounts 2025-02-01 2026-01-31 NI635541 uk-bus:AbridgedAccounts 2025-02-01 2026-01-31 NI635541 uk-core:ShareCapital 2026-01-31 NI635541 uk-core:ShareCapital 2025-01-31 NI635541 uk-core:RetainedEarningsAccumulatedLosses 2026-01-31 NI635541 uk-core:RetainedEarningsAccumulatedLosses 2025-01-31 NI635541 uk-core:TotalEquityAttributableToOwnersParentBeforeNon-controllingInterests 2026-01-31 NI635541 uk-core:TotalEquityAttributableToOwnersParentBeforeNon-controllingInterests 2025-01-31 NI635541 uk-bus:FRS102 2025-02-01 2026-01-31 NI635541 uk-core:Goodwill 2025-02-01 2026-01-31 NI635541 uk-core:PlantMachinery 2025-02-01 2026-01-31 NI635541 uk-core:FurnitureFittingsToolsEquipment 2025-02-01 2026-01-31 NI635541 uk-core:MotorVehicles 2025-02-01 2026-01-31 NI635541 uk-core:Goodwill 2025-01-31 NI635541 uk-core:Goodwill 2026-01-31 NI635541 2025-02-01 2026-01-31 NI635541 uk-bus:Director2 2025-02-01 2026-01-31 NI635541 uk-bus:AuditExempt-NoAccountantsReport 2025-02-01 2026-01-31 xbrli:pure iso4217:GBP xbrli:shares

Company Registration Number: NI635541

Magherafelt Healthcare Ltd

Abridged Unaudited Financial Statements

for the financial year ended 31 January 2026

Magherafelt Healthcare Ltd

Company Registration Number: NI635541

ABRIDGED BALANCE SHEET

as at 31 January 2026

|  |  | 2026 |  | 2025
|  | Notes | £ |  | £
Fixed Assets

Intangible assets |  | 4 | 1,755,993 |  | 1,910,741
Tangible assets |  | 5 | 566,865 |  | 541,596
|  |  | ───────── |  | ─────────
Fixed Assets |  |  | 2,322,858 |  | 2,452,337
|  |  | ───────── |  | ─────────
Current Assets

Stocks |  |  | 835,240 |  | 864,244
Debtors |  |  | 381,876 |  | 439,723
Cash and cash equivalents |  |  | 297,404 |  | 240,099
|  |  | ───────── |  | ─────────
|  |  | 1,514,520 |  | 1,544,066
|  |  | ───────── |  | ─────────
Creditors: amounts falling due within one year |  |  | (1,589,935) |  | (1,546,484)
|  |  | ───────── |  | ─────────
Net Current Liabilities |  |  | (75,415) |  | (2,418)
|  |  | ───────── |  | ─────────
Total Assets less Current Liabilities |  |  | 2,247,443 |  | 2,449,919
Creditors:

amounts falling due after more than one year |  |  | (1,569,370) |  | (1,753,237)
Provisions for liabilities |  |  | (141,716) |  | (135,399)
Government grants |  |  | (24,294) |  | -
|  |  | ───────── |  | ─────────
Net Assets |  |  | 512,063 |  | 561,283
|  |  | ═════════ |  | ═════════
Capital and Reserves

Called up share capital |  |  | 100 |  | 100
Retained earnings |  |  | 511,963 |  | 561,183
|  |  | ───────── |  | ─────────
Equity attributable to owners of the company |  |  | 512,063 |  | 561,283
|  |  | ═════════ |  | ═════════
The financial statements have been prepared in accordance with the provisions applicable to companies subject to the small companies' regime and in accordance with the provisions of FRS 102 Section 1A (Small Entities).

All of the members have consented to the preparation of abridged accounts in accordance with section 444(2A) of the Companies Act 2006.

The company has taken advantage of the exemption under section 444 not to file the Abridged Profit and Loss Account and Directors' Report.

For the financial year ended 31 January 2026 the company was entitled to exemption from audit under section 477 of the Companies Act 2006.

The directors confirm that the members have not required the company to obtain an audit of its financial statements for the financial year in question in accordance with section 476 of the Companies Act 2006.

The directors acknowledge their responsibilities for ensuring that the company keeps accounting records which comply with section 386 and for preparing financial statements which give a true and fair view of the state of affairs of the company as at the end of the financial year and of its profit and loss for the financial year in accordance with the requirements of sections 394 and 395 and which otherwise comply with the requirements of the Companies Act 2006 relating to financial statements, so far as applicable to the company.

Approved by the Board and authorised for issue on 29 April 2026 and signed on its behalf by

________________________________ |  |  |  |  |
Mr. John O'Brien |  |  |  |  |
Director |  |  |  |  |

Magherafelt Healthcare Ltd

NOTES TO THE ABRIDGED FINANCIAL STATEMENTS

for the financial year ended 31 January 2026

1. | General Information
| Magherafelt Healthcare Ltd is a company limited by shares incorporated in Northern Ireland. The registered office of the company is 5 Broad Street, Magherafelt, BT45 6EB, Northern Ireland. The financial statements have been presented in Pound (£) which is also the functional currency of the company.

2. | Summary of Significant Accounting Policies
| The following accounting policies have been applied consistently in dealing with items which are considered material in relation to the company's financial statements.
| Statement of compliance
| The financial statements of the company for the year ended 31 January 2026 have been prepared in accordance with the provisions of FRS 102 Section 1A (Small Entities) and the Companies Act 2006.
| Basis of preparation
| The financial statements have been prepared on the going concern basis and in accordance with the historical cost convention except for certain properties and financial instruments that are measured at revalued amounts or fair values, as explained in the accounting policies below. Historical cost is generally based on the fair value of the consideration given in exchange for assets. The going concern basis assumes that the company will continue in operational existence for the foreseeable future, having adequate funds to meet its obligations as they fall due. After making enquiries the directors have a reasonable expectation that the company will have adequate resources to continue in operational existence for the foreseeable future.
| Turnover
| Turnover comprises the invoice value of goods supplied by the company, exclusive of trade discounts and value added tax.
| Goodwill
| Purchased goodwill arising on the acquisition of a business represents the excess of the acquisition cost over the fair value of the identifiable net assets including other intangible fixed assets when they were acquired. Purchased goodwill is capitalised in the Balance Sheet and amortised on a straight line basis over its economic useful life of 20 years, which is estimated to be the period during which benefits are expected to arise. On disposal of a business any goodwill not yet amortised is included in determining the profit or loss on sale of the business.
| Tangible assets and depreciation
| Tangible assets are stated at cost or at valuation, less accumulated depreciation. The charge to depreciation is calculated to write off the original cost or valuation of tangible assets, less their estimated residual value, over their expected useful lives as follows:
|  | Plant and machinery | - | 15% Straight line
|  | Fixtures, fittings and equipment | - | 20% Reducing Balance
|  | Motor vehicles | - | 25% Straight line
| The carrying values of tangible fixed assets are reviewed annually for impairment in periods if events or changes in circumstances indicate the carrying value may not be recoverable.
| Stocks
| Stocks are valued at the lower of cost and net realisable value. Stocks are determined on a first-in first-out basis. Cost comprises expenditure incurred in the normal course of business in bringing stocks to their present location and condition. Full provision is made for obsolete and slow moving items. Net realisable value comprises actual or estimated selling price (net of trade discounts) less all further costs to completion or to be incurred in marketing and selling.
| Trade and other debtors
| Trade and other debtors are initially recognised at fair value and thereafter stated at amortised cost using the effective interest method less impairment losses for bad and doubtful debts except where the effect of discounting would be immaterial. In such cases the receivables are stated at cost less impairment losses for bad and doubtful debts.
| Borrowing costs
| Borrowing costs relating to the acquisition of assets are capitalised at the appropriate rate by adding them to the cost of assets being acquired. Investment income earned on the temporary investment of specific borrowings pending their expenditure on the assets is deducted from the borrowing costs eligible for capitalisation. All other borrowing costs are recognised in profit or loss in the period in which they are incurred.
| Provisions
| Provisions are recognised when the company has a present legal or constructive obligation arising as a result of a past event, it is probable that an outflow of economic benefits will be required to settle the obligation and a reliable estimate can be made. Provisions are measured at the present value of the expenditures expected to be required to settle the obligation using a pre-tax rate that reflects current market assessments of the same value of money and the risks specific to the obligation. The increase in the provision due to passage of time is recognised as interest expense.
| Trade and other creditors
| Trade and other creditors are initially recognised at fair value and thereafter stated at amortised cost using the effective interest rate method, unless the effect of discounting would be immaterial, in which case they are stated at cost.
| Employee benefits
| The company operates a defined contribution pension scheme. The assets of the scheme are held separately from those of the company in an independently administered fund.
| Taxation and deferred taxation
| Current tax represents the amount expected to be paid or recovered in respect of taxable profits for the financial year and is calculated using the tax rates and laws that have been enacted or substantially enacted at the Balance Sheet date. Deferred tax is recognised in respect of all timing differences that have originated but not reversed at the balance sheet date where transactions or events have occurred at that date that will result in an obligation to pay more tax in the future, or a right to pay less tax in the future. Timing differences are temporary differences between the company's taxable profits and its results as stated in the financial statements. Deferred tax is measured on an undiscounted basis at the tax rates that are anticipated to apply in the periods in which the timing differences are expected to reverse, based on tax rates and laws that have been enacted or substantively enacted by the balance sheet date.
| Government grants
| Capital grants received and receivable are treated as deferred income and amortised to the Profit and Loss Account annually over the useful economic life of the asset to which it relates. Revenue grants are credited to the Profit and Loss Account when received.
| Ordinary share capital
| The ordinary share capital of the company is presented as equity.

3. | Employees
| The average monthly number of employees, including directors, during the year was as follows:
|  | 2026 | 2025
|  | Number | Number
| Employees | 58 | 50
|  | ═════════ | ═════════

4. | Intangible assets
|  | Goodwill
|  | £
| Cost
| At 1 February 2025 | 3,094,960
|  | ─────────
| At 31 January 2026 | 3,094,960
|  | ─────────
| Amortisation
| At 1 February 2025 | 1,184,219
| Charge for financial year | 154,748
|  | ─────────
| At 31 January 2026 | 1,338,967
|  | ─────────
| Net book value
| At 31 January 2026 | 1,755,993
|  | ═════════
| At 31 January 2025 | 1,910,741
|  | ═════════

5. | Tangible assets
|  | Plant and | Fixtures, | Motor | Total
|  | machinery | fittings and | vehicles |
|  |  | equipment |  |
|  | £ | £ | £ | £
| Cost
| At 1 February 2025 | - | 1,097,046 | 30,050 | 1,127,096
| Additions | 115,680 | 22,559 | - | 138,239
|  | ───────── | ───────── | ───────── | ─────────
| At 31 January 2026 | 115,680 | 1,119,605 | 30,050 | 1,265,335
|  | ───────── | ───────── | ───────── | ─────────
| Depreciation
| At 1 February 2025 | - | 576,399 | 9,101 | 585,500
| Charge for the financial year | 2,189 | 106,591 | 4,190 | 112,970
|  | ───────── | ───────── | ───────── | ─────────
| At 31 January 2026 | 2,189 | 682,990 | 13,291 | 698,470
|  | ───────── | ───────── | ───────── | ─────────
| Net book value
| At 31 January 2026 | 113,491 | 436,615 | 16,759 | 566,865
|  | ═════════ | ═════════ | ═════════ | ═════════
| At 31 January 2025 | - | 520,647 | 20,949 | 541,596
|  | ═════════ | ═════════ | ═════════ | ═════════

6. | Capital commitments
| The company had no material capital commitments at the financial year-ended 31 January 2026.